Why Asthma Research Matters in the UK Right Now
The UK has one of the highest asthma prevalence rates in Europe. Around 5.4 million people receive treatment for the condition, and the NHS spends roughly £1 billion annually on asthma-related care. Yet a significant portion of people with asthma—particularly those with severe or hard-to-treat forms—still struggle to achieve good symptom control. This is where clinical trials come in.
What many people do not realise is how active the UK is in respiratory research. The National Institute for Health and Care Research (NIHR) runs a dedicated respiratory translational research network that connects hospitals, universities, and GP practices across England, Scotland, Wales, and Northern Ireland. Trials are not confined to London teaching hospitals either. You will find studies recruiting in cities like Leicester, Manchester, Birmingham, Southampton, Glasgow, and Belfast. Some even allow remote participation through digital monitoring tools and home visits.
The types of trials vary widely. Some investigate biologic therapies for severe asthma—injectable medicines that target specific inflammatory pathways rather than using broad steroids. Others look at smart inhaler technology that tracks usage patterns and gives feedback through a smartphone app. There are also studies on dietary interventions and asthma control, breathing retraining programmes, and early-life prevention strategies for children at risk of developing the condition.
Finding the Right Trial for Your Situation
Not every trial suits every person, and that is actually a good thing. The eligibility criteria exist to keep participants safe and to make sure researchers get meaningful results. Here is a broad look at the kinds of studies available:
| Trial Type | Who It Might Suit | Typical Duration | What Is Involved | Potential Considerations |
|---|
| Biologic therapy trials | Adults with severe eosinophilic or allergic asthma uncontrolled on high-dose ICS/LABA | 6–24 months | Regular injections or infusions, blood tests, lung function monitoring | May require hospital visits every 2–8 weeks; some studies are placebo-controlled |
| Smart inhaler / digital health studies | Adults and children using regular preventer inhalers | 3–12 months | Using a device that attaches to your inhaler, syncing data via an app | Minimal travel; may involve answering questionnaires online |
| Breathing technique / physiotherapy trials | People with asthma and dysfunctional breathing patterns | 8–16 weeks | Attending group or one-to-one sessions with a respiratory physiotherapist | Requires commitment to regular sessions; often non-pharmacological |
| Diet and lifestyle intervention studies | Adults with obesity-related asthma or exercise-induced symptoms | 3–6 months | Following a specific dietary plan, keeping food and symptom diaries | May include cooking workshops or supermarket guidance sessions |
| Paediatric prevention trials | Children with family history of asthma or early wheezing episodes | 1–5 years | Regular check-ups, skin prick tests, occasional blood draws | Parental involvement is essential; some studies are observational only |
The table above gives a snapshot, but the reality is that each trial has its own detailed protocol. Reading the participant information sheet carefully before signing up is essential.
What Actually Happens When You Join a Trial
There is a common misconception that joining a clinical trial means being treated like a guinea pig. The experience tends to be far more structured and supportive than that. Take Rachel, a 42-year-old teacher from Sheffield who had been on high-dose inhaled steroids for years but still woke up coughing most nights. She joined a biologic therapy trial at her local severe asthma centre after her consultant mentioned it during a routine review.
The process started with a screening visit where the research team explained the study in detail, checked her medical history, and ran baseline tests including spirometry and blood work. Once she was confirmed eligible, she began attending the clinic every four weeks for an injection. The trial covered her travel costs, and she always saw the same research nurse, which she found reassuring. Her asthma control improved noticeably within three months, and while she knows it might be the placebo effect or the drug itself—the trial is still blinded—she values the extra monitoring and support regardless.
Another participant, James, a 28-year-old software developer in Bristol, joined a digital inhaler study that required nothing more than attaching a small sensor to his preventer inhaler. The app showed him how often he was using his reliever and flagged patterns he had not noticed, like a spike in symptoms on weekday mornings. He never had to visit a hospital; everything was managed remotely.
These stories highlight something important: trials are not just about the experimental treatment. They offer closer monitoring, regular contact with respiratory specialists, and often a deeper understanding of your own condition.
How to Navigate the Process
The first step is usually a conversation with your GP or asthma nurse. They can tell you whether there are local studies recruiting and whether you might be a suitable candidate. If you are under a hospital consultant, that route is often even more direct. Consultants in severe asthma centres are frequently involved in research and can refer you to trials they are running or collaborating on.
You can also search independently. The NIHR Be Part of Research website lists studies across the UK and lets you filter by condition, location, and trial type. Asthma + Lung UK maintains a clinical trials hub that explains current opportunities in plain English. The international registry ClinicalTrials.gov is another useful tool, though it requires some patience to navigate.
Once you find a trial that interests you, the research team will guide you through a process called informed consent. This is not just a form to sign. It is a conversation where you learn about the study's purpose, what participation involves, any risks, and your right to withdraw at any time without affecting your usual care.
Some practical points worth knowing: many trials reimburse travel expenses and some offer compensation for time. You do not need to stop your regular medications unless the trial protocol specifically asks you to. And if you are assigned to a placebo group in a randomised controlled trial, you will still receive your standard asthma care throughout.
What to Ask Before You Say Yes
Walking into a research clinic with a list of questions is entirely reasonable. The research team expects it. Here are a few that experienced participants suggest:
- What is the purpose of this study and what phase is it in?
- How many visits will I need to attend and where?
- Will I need to change my current medications?
- What happens if my asthma gets worse during the trial?
- Will I find out which treatment I received after the study ends?
- Are there any known side effects from the treatment being tested?
- Can I continue seeing my usual GP and consultant during the trial?
The answers should be clear and satisfactory. If they are not, take your time. A good research team will never pressure you into a decision.
Regional Resources Across the UK
Different parts of the UK have different strengths in asthma research. The Royal Brompton Hospital in London and the University of Leicester are both internationally recognised for respiratory studies. The Manchester University NHS Foundation Trust runs one of the largest severe asthma services in the country and frequently recruits for biologic trials. In Scotland, the Scottish Respiratory Research Network coordinates asthma studies across Glasgow, Edinburgh, Dundee, and Aberdeen. Northern Ireland has active paediatric asthma research through the Royal Belfast Hospital for Sick Children.
For those who live in more rural areas, a growing number of trials now use remote monitoring technology, meaning you might only need to visit a clinic once or twice, with the rest managed through video calls, online questionnaires, and devices sent to your home.
The landscape of asthma research in the UK keeps shifting. New biologic agents, combination inhalers, and digital health tools are tested every year. The NIHR and Asthma + Lung UK websites remain the most reliable starting points for anyone curious about what is currently available. If your asthma has been bothering you more than usual, or if your current treatment simply is not doing enough, asking your GP whether there is a trial that might fit your situation could open a door you did not know existed.
研究の知恵